Physician Wealth Advisors’s Faeth Therapeutics FTH Stock Holding History

Physician Wealth Advisors’s Portfolio FTH Stock Details FTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$833	Hold	28	–	–	﹤0.01%	2023
2026 Q2	$700	Buy	+28	New	+$648	﹤0.01%	1958

Other funds holding FTH

Financial Consulate Hunt Valley, Maryland $899M AUM 14.82% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Physician Wealth Advisors's FTH Position: Q3 2026 in Review

Physician Wealth Advisors held its Faeth Therapeutics (FTH) position steady in Q3 2026 at 28 shares worth $833. The position accounts for ﹤0.01% of the portfolio, ranked #2023.

Physician Wealth Advisors first reported a position in FTH in Q2 2026 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold FTH as of Q3 2026.

Physician Wealth Advisors held 28 shares of Faeth Therapeutics worth $833 as of Q3 2026.
Physician Wealth Advisors left its Faeth Therapeutics share count unchanged in Q3 2026.
Faeth Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #2023 holding.
Physician Wealth Advisors first reported a position in Faeth Therapeutics in Q2 2026 and has held it in 2 quarters since.
4 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.